Photo: Roberto Machado Noa/LightRocket via Getty Images

The Trump administration is moving forward with new rules that would require drug companies to disclose their prices, rejecting the industry’s efforts to preempt those regulations.

Why it matters: This is the most direct conflict yet between pharmaceutical companies and the administration, and the dispute could quickly escalate into the courts.

Details: The Health and Human Services Department is expected to release new rules today that would require pharmaceutical companies to include drugs’ sticker prices in their TV ads, similar to the way they disclose side effects.

  • Drugmakers tried to preempt those rules this morning by offering an implicit compromise. PhRMA, the industry's leading trade group, said its members would voluntarily include statements, in voiceover or text, that direct viewers to websites where they can find pricing information, but would not include prices themselves in their ads.
  • "The drug industry remains resistant to providing real transparency around their prices, including the sky-high list prices that many patients pay," HHS Secretary Alex Azar said in a statement. "So while the pharmaceutical industry’s action today is a small step in the right direction, we will go further."

What’s next: PhRMA declined to explicitly threaten a lawsuit before seeing the regulations, but said mandatory list-price disclosures “would raise significant legal issues, including First Amendment concerns.”

Go deeper

Updated 30 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 7 a.m. ET: 30,804,120 — Total deaths: 957,348— Total recoveries: 21,062,785Map.
  2. U.S.: Total confirmed cases as of 7 a.m. ET: 6,766,631 — Total deaths: 199,268 — Total recoveries: 2,577,446 — Total tests: 94,211,463Map.
  3. Education: What we overlooked in the switch to remote learning
  4. Politics: In reversal, CDC again recommends coronavirus testing for asymptomatic people.
  5. Health: The dwindling chances of eliminating COVID-19.
  6. World: Guatemalan president tests positive for COVID-19 — The countries painting their pandemic recoveries green.

What we overlooked in the switch to remote learning

Illustration: Eniola Odetunde/Axios

America’s rapid and urgent transition to online school has come with a host of unforeseen consequences that are only getting worse as it continues into the fall.

The big picture: The issues range from data privacy to plagiarism, and schools are ill-equipped to deal with them, experts say.

The positions of key GOP senators on replacing Ruth Bader Ginsburg

Senate Majority Leader Mitch McConnell talks to reporters on Capitol Hill last Thursday. Photo: Chip Somodevilla/Getty Images

With President Trump planning to nominate his third Supreme Court justice nominee by next week, key Republican senators are indicating their stance on replacing the late Justice Ruth Bader Ginsburg just over six weeks out from Election Day.

The big picture: Senate Majority Leader Mitch McConnell (Ky.) has vowed that "Trump’s nominee will receive a vote on the floor of the United States Senate." But Sen. Lisa Murkowski (Alaska) told Alaska Public Media, "I would not vote to confirm a Supreme Court nominee. We are 50 some days away from an election."